US Patent Issued to Massachusetts Institute of Technology on Sept. 22 for "Selective MCL-1 binding peptides" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,997, issued on Sept. 22, was assigned to Massachusetts Institute of Technology (Cambridge, Mass.). "Selective MCL-1 binding peptides" was ... Read More

US Patent Issued to VIB VZW, UNIVERSITEIT GENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE MONTPELLIER on Sept. 22 for "Targeting of human interferon antagonists" (Belgian, French Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,998, issued on Sept. 22, was assigned to VIB VZW (Ghent, Belgium), UNIVERSITEIT GENT (Ghent, Belgium), CENTRE NATIONAL DE LA RECHERCHE SCIE... Read More

US Patent Issued to ELI LILLY and Co. on Sept. 22 for "Incretin analogs and uses thereof" (Indiana Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,999, issued on Sept. 22, was assigned to ELI LILLY AND COMPANY (Indianapolis). "Incretin analogs and uses thereof" was invented by Jorge A... Read More

US Patent Issued to Akston Biosciences on Sept. 22 for "Insulin-Fc fusion proteins and methods of use to treat cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,000, issued on Sept. 22, was assigned to Akston Biosciences Corp. (Beverly, Mass.). "Insulin-Fc fusion proteins and methods of use to trea... Read More

US Patent Issued to ST. JUDE CHILDREN'S RESEARCH HOSPITAL on Sept. 22 for "Chimeric antigen receptors with CD20 safety switch" (Tennessee Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,001, issued on Sept. 22, was assigned to ST. JUDE CHILDREN'S RESEARCH HOSPITAL INC. (Memphis, Tenn.). "Chimeric antigen receptors with CD2... Read More

US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Sept. 22 for "Engineered T cell receptors and methods of use" (Texas Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,002, issued on Sept. 22, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas). "Engineered T cell receptors an... Read More

US Patent Issued to Hoffmann-La Roche on Sept. 22 for "Multistep final filtration" (German Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,003, issued on Sept. 22, was assigned to Hoffmann-La Roche Inc. (Branchburg, N.J.). "Multistep final filtration" was invented by Roberto F... Read More

US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 22 for "Pharmaceutical composition containing antibody against IL-5 and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,004, issued on Sept. 22, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD... Read More

US Patent Issued to SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) on Sept. 22 for "Human IL-33 antibodies, preparation method and conjugates thereof and method of use thereof for treatment" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,005, issued on Sept. 22, was assigned to SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) Co. LTD. (Shanghai). "Human IL-33 antibodies, preparat... Read More

US Patent Issued to KOBENHAVNS UNIVERSITET on Sept. 22 for "GLP1R agonist NMDAR antagonist conjugates" (Danish Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,006, issued on Sept. 22, was assigned to KOBENHAVNS UNIVERSITET (Copenhagen K, Denmark). "GLP1R agonist NMDAR antagonist conjugates" was i... Read More

• ««
• «
• 73798
• 73799
• 73800
• 73801
• 73802
• 73803
• 73804
• 73805
• 73806
• 73807
• »
• »»